Welcome to LookChem.com Sign In|Join Free
  • or
rac-succinic acid mono-(4-{18-[4-(3-carboxy-propionyloxy)-2,6,6-trimethyl-3-oxo-cyclohex-1-enyl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl}-3,5,5-trimethyl-2-oxo-cyclohex-3-enyl) ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

769935-71-9

Post Buying Request

769935-71-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

769935-71-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 769935-71-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,9,9,3 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 769935-71:
(8*7)+(7*6)+(6*9)+(5*9)+(4*3)+(3*5)+(2*7)+(1*1)=239
239 % 10 = 9
So 769935-71-9 is a valid CAS Registry Number.

769935-71-9Downstream Products

769935-71-9Relevant academic research and scientific papers

The efficient synthesis of disodium disuccinate astaxanthin (Cardax)

Frey, Dean A.,Kataisto, Erik W.,Ekmanis, Juris L.,O'Malley, Sean,Lockwood, Samuel F.

, p. 796 - 801 (2004)

A practical procedure is described for the multigram preparation of disodium disuccinate derivatives of synthetic astaxanthin (Cardax) [from all-trans-(all-E)-3S,3′S-, meso-(3R,3′S)-, and 3R,3′R- dihydroxy-β,β-carotene-4,4′-dione) in a 1:2:1 statistical m

SMALL MOLECULE COMPOUNDS TO SUPPORT HEALTHY HUMAN AGING

-

Page/Page column 34; 35, (2018/10/25)

Disclosed herein are methods of activating expression of the FOXO3 gene in a subject comprising administering to a subject small molecule compound (such as astaxanthin and/or one or more astaxanthin derivatives), or pharmaceutically acceptable salts there

STRUCTURAL CAROTENOID ANALOGS FOR THE INHIBITION AND AMELIORATION OF DISEASE

-

Page 36-37, (2008/06/13)

A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid structural analog, either a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 769935-71-9